Formulation Featured Articles

  1. Report: Five Clinical Areas Most Likely To Benefit From DNA Sequencing 11/13/2012

    The idea of a patient's DNA being routinely tested by a next-generation sequencer to help a doctor make a diagnosis may seem a bit futuristic right now. But Kalorama Information suggests that sequencers are expected to see usage in at least five clinical areas over the next several years.

  2. Lonza And OncoMed Pharmaceuticals Sign A Process Development And Manufacturing Collaboration And Multi-Product GS License Agreement For Anti-Cancer Therapeutics 10/23/2012

    Lonza, a global leader in biological manufacturing and OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced recently an agreement for the development and manufacture of OncoMed’s pipeline of anti-cancer stem cell therapeutics.

  3. GE Healthcare Launches Ni Sepharose Excel Chromatography Media For Direct Purification Of Histidine-Tagged Proteins Secreted From Eukaryotic Expression Systems 8/21/2012

    GE Healthcare’s Ni Sepharose excel is an immobilized metal ion affinity chromatography (IMAC) medium (resin) for the direct capture and purification of secreted histidine-tagged recombinant proteins from eukaryotic cell culture supernatants. 

  4. New HQ For Lab M Heralds Exciting Phase In Company's Development 5/30/2012

    Lab M’s move into new global headquarters, in June 2012, represents the most significant investment in the microbiology company’s more than 40-year history.

  5. 3M Purification Inc. Introduces New Zeta Plus Encapsulated, Single-Use Depth Filtration Products 5/4/2012

    3M Purification Inc. has expanded its portfolio of Encapsulated Zeta Plus single-use depth filtration capsules.  The two new product lines – Zeta Plus Scale-up Capsule Filters and new single-layer media grades for Zeta Plus Encapsulated capsules – are designed with our industry leading Zeta Plus depth filter media, designed for applications in the bio-pharmaceutical industry including cell culture clarification, downstream process protection, virus, DNA and lipid reduction, and host cell protein (HCP), protein aggregate, endotoxin and anti-foaming agent removal.

  6. Market Research Projects Media, Sera & Reagents Markets In Biotechnology At $4.2B By 2016 4/24/2012

    MarketResearch.com has announced the addition of the new report "Global Markets for Media, Sera and Reagents in Biotechnology," to their collection of Biotechnology market reports. 

  7. Increase Your Biologics Candidates' Success With Dynamic Light Scattering

    To determine colloidal stability of biologics candidates, scientists rely on particle size and dispersity in solution using DLS experiments. Learn how five formulation changes affect the DLS read-out.

  8. Turbulent Mixing: Scaling Up Nanoparticle Manufacturing For The Future

    Choosing between turbulent and microfluidic mixing methods in your lipid nanoparticle (LNP) production can have a significant impact when scaling up production.

  9. Raw Materials Risk Mitigation And Management

    Protecting your raw materials is a vital part of your process – and one that should be taken seriously. Repercussions like plant shut-downs and drug shortages — stemming from events like virus contamination — can be far-reaching and difficult to overcome. To help safeguard your product, and to avoid potential adverse events, you can keep the following things in mind when sourcing media.

  10. Mechanisms Of LNP-Mediated mRNA Delivery

    Explore the details supporting LNP-mediated mRNA delivery, as well as the challenges facing mRNA based therapeutics in the future.